A pharmacotherapy for obstructve sleep apnea [1]

Sleep

Volumn 28, Issue 8, 2005, Pages 1015-1016

  Sasse, Anthony ^a   Conduit, Russell ^b   Ryan, David ^c   Woods, William ^c   Tucker, Adam P ^d  

^a Laffayette Specialist Centre   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c CSL LIMITED   (Australia)

^d MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TETANUS TOXIN; METALLOPROTEINASE; MUSCLE RELAXANT AGENT; TETANOSPASMIN;

BREATHING MECHANICS; BREATHING MUSCLE; BREATHING PATTERN; DOG; DOSE RESPONSE; DRUG EFFECT; ELECTROMYOGRAM; LETTER; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; SLEEP; SLEEP APNEA SYNDROME; HUMAN; NOTE;

HUMANS; METALLOENDOPEPTIDASES; NEUROMUSCULAR AGENTS; SLEEP APNEA, OBSTRUCTIVE; TETANUS TOXIN;

EID: 23844498430     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/28.8.1015     Document Type: Letter

References (5)

1. Veasey SC. Will we ever have an effective pharmacotherapy for obstructive sleep apnea? Sleep 2005;28:18-9.
2. Tucker AP, Mezzatesta J, Nadeson R, Goodchild CS. Intrathecal midazolam II: combination with intrathecal fentanyl for labor pain. Anesth Analg 2004;98:1521-7.
3. Beard S, Hunn A, Wight J. Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technol Assess 2003;7: iii, ix-x: 1-111.
4. Dhonneur G, Combes X, Leroux B, Duvaldestin P. Postoperative obstructive apnea. Anesth Analg 1999;89:762-7.
5. Veasey SC, Chachkes J, Fenik P, Hendricks JC. The effects of ondansetron on sleep-disordered breathing in the English bulldog. Sleep 2001;24:155-60.